TOPLINE: Patients with type 2 diabetes (T2D) who received glucagon-like peptide 1 (GLP-1) receptor agonists had a significantly lower risk of developing local or systemic complications — even if ...

The analysis found that each tertile increase in PFAS mixture exposure was associated with a 31% higher likelihood of developing T2D (OR, 1.31; 95% CI, 1.01-1.70), with perfluorooctane sulfonate ...

The study included 10,346 children with overweight or obesity but without T2D at baseline (median age, 12.5 years; 43.1% girls; 1102 with MASLD) and 59,336 matched control individuals from the ...

The T2D cohort was similarly split into cohorts 1b for T2D + tirzepatide (n = 4223) and 2b for T2D + semaglutide (n = 4223). In both the groups, the mean age of participants was 53.9-54 years; 60% ...